Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	415.52	546.09	246.55	398.7	354.24
Cash & Short-Term Investments	415.52	546.09	246.55	398.7	354.24
Cash Growth	-23.91%	121.50%	-38.16%	12.55%	121.47%
Accounts Receivable	117.29	98.13	94.5	52.04	40.18
Other Receivables	23.74	20.25	9.76	11.88	3.52
Receivables	141.04	118.37	104.26	63.91	43.7
Inventory	227.41	141.6	106.57	77.59	59.35
Prepaid Expenses	29.11	20.34	10.14	7.34	5.94
Total Current Assets	813.08	826.41	467.51	547.53	463.23
Property, Plant & Equipment	149.04	97.55	47.58	26.3	21.33
Long-Term Investments	0.9	0.58	0.41	1.16	0.75
Goodwill	682.48	591.39	625.32	460.23	223.94
Other Intangible Assets	48.7	30.46	8.49	8.66	6.75
Long-Term Deferred Tax Assets	32.45	50.71	39.27	42.17	40.33
Long-Term Deferred Charges	676.09	598.51	544.51	456.55	393.97
Total Assets	2,403	2,196	1,733	1,543	1,150
Accounts Payable	39.45	36.05	38.47	21.45	14.47
Accrued Expenses	85.08	68.94	52.65	46.96	48.9
Current Portion of Leases	10.92	10.27	5.55	4.2	3.93
Current Income Taxes Payable	11.93	11.87	1.28	0.3	-
Current Unearned Revenue	13.47	3.69	3.17	3.01	3.72
Other Current Liabilities	16.67	3.66	33.77	28.6	1.24
Total Current Liabilities	177.51	134.49	134.9	104.52	72.25
Long-Term Leases	23.13	21.17	4.46	1.52	3.29
Long-Term Deferred Tax Liabilities	27.85	29.29	25.77	25.08	24.85
Other Long-Term Liabilities	17.48	65.62	137.83	126.02	41.46
Total Liabilities	245.97	250.57	302.95	257.15	141.85
Common Stock	0.81	0.81	0.76	0.75	0.73
Additional Paid-In Capital	1,772	1,764	1,314	1,253	1,007
Retained Earnings	291.76	119.57	27.75	9.28	1.13
Comprehensive Income & Other	92.19	60.89	87.78	22.09	-0.18
Shareholders' Equity	2,157	1,945	1,430	1,285	1,008
Total Liabilities & Equity	2,403	2,196	1,733	1,543	1,150
Total Debt	34.04	31.44	10.01	5.72	7.21
Net Cash (Debt)	381.48	514.65	236.54	392.98	347.02
Net Cash Growth	-25.88%	117.58%	-39.81%	13.24%	124.76%
Net Cash Per Share	12.05	17.19	8.01	13.58	12.77
Filing Date Shares Outstanding	31.5	31.5	29.83	29.5	28.72
Total Common Shares Outstanding	31.5	31.5	29.83	29.5	28.72
Working Capital	635.57	691.92	332.61	443.01	390.98
Book Value Per Share	68.47	61.75	47.94	43.58	35.11
Tangible Book Value	1,426	1,323	796.33	816.56	777.77
Tangible Book Value Per Share	45.26	42.01	26.69	27.68	27.08
Machinery	217.57	153.61	98.52	68.04	58.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.